Safety and tolerability of a first in class chymase inhibitor in clinically stable patients with left-ventricular dysfunction after myocardial infarction
29 May 2018 (08:00 - 12:30)
Organised by:
Abstract
About the speaker
Papa Giovanni XXIII Hospital, Bergamo (Italy)
25 More presentations in this session
Access the full session
The Event
Heart Failure 2018
29 May 2018
08:00 CET
You may be interested in
Congress Session
